Disclosures for "Multi-Centre Audit Of Myotonic Dystrophy In the UK: How Can We Improve Access to Care?")
-
Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARENX. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Hewamadduma has received research support from Neurocare . The institution of Dr. Hewamadduma has received research support from Sheffield Charitable Trust. Dr. Hewamadduma has received personal compensation in the range of $5,000-$9,999 for serving as a Adult Expert with National Health Service England (NHSE).
-
Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
-
Mr. Kelly has nothing to disclose.
-
Miss White has nothing to disclose.
-
Mr. Whiter has nothing to disclose.
-
Dr. Islam has nothing to disclose.
-
Dr. Campbell has nothing to disclose.
-
Dr. Mehboob has nothing to disclose.
-
Dr. Vonberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prova Health.
-
Dr. Shanmugarajah has nothing to disclose.
-
Dr. Grote has nothing to disclose.
-
Dr. Viegas has nothing to disclose.
-
Dr. Turner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Turner Partnership. The institution of Dr. Turner has received research support from MDUK.